IL108648A0 - Condensed five-membered heterocyclic compounds, their preparation and pharmaceutical compositions containing them - Google Patents
Condensed five-membered heterocyclic compounds, their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL108648A0 IL108648A0 IL10864894A IL10864894A IL108648A0 IL 108648 A0 IL108648 A0 IL 108648A0 IL 10864894 A IL10864894 A IL 10864894A IL 10864894 A IL10864894 A IL 10864894A IL 108648 A0 IL108648 A0 IL 108648A0
- Authority
- IL
- Israel
- Prior art keywords
- condensed
- preparation
- pharmaceutical compositions
- compositions containing
- membered heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4304650A DE4304650A1 (en) | 1993-02-16 | 1993-02-16 | Condensed 5-membered heterocycles, processes for their preparation and pharmaceutical compositions containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
IL108648A0 true IL108648A0 (en) | 1994-05-30 |
Family
ID=6480585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10864894A IL108648A0 (en) | 1993-02-16 | 1994-02-15 | Condensed five-membered heterocyclic compounds, their preparation and pharmaceutical compositions containing them |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0611660A3 (en) |
JP (1) | JPH072839A (en) |
AU (1) | AU5513094A (en) |
CA (1) | CA2115737A1 (en) |
DE (1) | DE4304650A1 (en) |
FI (1) | FI940697A (en) |
IL (1) | IL108648A0 (en) |
NO (1) | NO940524D0 (en) |
NZ (1) | NZ250879A (en) |
ZA (1) | ZA941021B (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2751647B1 (en) * | 1996-07-25 | 1998-09-11 | Synthelabo | BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATIONS AND THEIR THERAPEUTIC APPLICATIONS |
WO1999020624A1 (en) | 1997-10-20 | 1999-04-29 | F.Hoffmann-La Roche Ag | Bicyclic kinase inhibitors |
HUP0303258A3 (en) | 2001-02-23 | 2004-06-28 | Merck & Co Inc | N-substituted nonaryl-heterocyclic nmda/nr2b antagonists and pharmaceutical compositions containing them |
MXPA04004301A (en) | 2001-11-09 | 2004-08-11 | Boehringer Ingelheim Pharma | Benzimidazoles useful as protein kinase inhibitors. |
WO2004014905A1 (en) | 2002-08-08 | 2004-02-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted benzimidazole compounds |
ATE524741T1 (en) | 2002-12-19 | 2011-09-15 | Scripps Research Inst | COMPOSITIONS AND USES FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING |
EP1479676A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Benzimidazole-derivatives as factor xa inhibitors |
US7741341B2 (en) | 2003-05-19 | 2010-06-22 | Sanofi-Aventis Deutschland Gmbh | Benzimidazole-derivatives as factor Xa inhibitors |
US7511145B2 (en) | 2003-08-01 | 2009-03-31 | Genelabs Technologies, Inc. | Bicyclic heteroaryl derivatives |
JP2007538103A (en) | 2004-05-20 | 2007-12-27 | ザ スクリップス リサーチ インスティテュート | Transthyretin stabilization |
US9522916B2 (en) * | 2007-12-21 | 2016-12-20 | Constance Neely Wilson | A1 adenosine receptor antagonists |
WO2013038351A1 (en) | 2011-09-16 | 2013-03-21 | Pfizer Inc. | Solid forms of a transthyretin dissociation inhibitor |
EP2956450B1 (en) | 2013-02-14 | 2018-07-25 | Technische Universität München | Hydroxyindalpine derivatives and their medical use |
WO2014151729A1 (en) | 2013-03-15 | 2014-09-25 | Irm Llc | Compounds and compositions for the treatment of parasitic diseases |
US9233961B2 (en) | 2013-03-15 | 2016-01-12 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
DK2970303T6 (en) | 2013-03-15 | 2018-10-08 | Hydra Biosciences Inc | SUBSTITUTED XANTHINES AND PROCEDURES FOR USING IT |
US9296754B2 (en) | 2013-03-15 | 2016-03-29 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
MA39186A1 (en) | 2013-12-19 | 2017-11-30 | Novartis Ag | Derivatives of [1,2,4] triazolo [1,5-a] pyrimidine used as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis |
JP6403865B2 (en) * | 2014-07-03 | 2018-10-10 | シャンハイ インスティテュート オブ ファーマシューティカル インダストリー | Method for producing dabigatran etexilate intermediate and intermediate compound |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2208367B (en) | 1987-07-09 | 1991-07-03 | Alcatel Business Systems | Franking machine |
US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
DE4124942A1 (en) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS |
DE4129603A1 (en) * | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | CONDENSED 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THESE COMPOUNDS |
DE4214245A1 (en) * | 1992-04-30 | 1993-11-04 | Thomae Gmbh Dr K | Labelled fibrinogen receptor antagonists |
ES2092170T3 (en) * | 1992-04-28 | 1996-11-16 | Thomae Gmbh Dr K | TRITIO-MARKED FIBRINOGEN RECEPTOR ANTAGONISTS, THEIR USE AND PROCEDURE FOR THEIR PREPARATION. |
-
1993
- 1993-02-16 DE DE4304650A patent/DE4304650A1/en not_active Withdrawn
-
1994
- 1994-02-14 EP EP9494102222A patent/EP0611660A3/en not_active Withdrawn
- 1994-02-14 JP JP6017568A patent/JPH072839A/en active Pending
- 1994-02-15 CA CA002115737A patent/CA2115737A1/en not_active Abandoned
- 1994-02-15 NO NO940524A patent/NO940524D0/en unknown
- 1994-02-15 ZA ZA941021A patent/ZA941021B/en unknown
- 1994-02-15 FI FI940697A patent/FI940697A/en not_active Application Discontinuation
- 1994-02-15 IL IL10864894A patent/IL108648A0/en unknown
- 1994-02-15 NZ NZ250879A patent/NZ250879A/en unknown
- 1994-02-15 AU AU55130/94A patent/AU5513094A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO940524L (en) | 1994-08-17 |
AU5513094A (en) | 1994-08-18 |
NZ250879A (en) | 1995-09-26 |
EP0611660A3 (en) | 1994-09-14 |
CA2115737A1 (en) | 1994-08-17 |
FI940697A0 (en) | 1994-02-15 |
ZA941021B (en) | 1995-08-15 |
EP0611660A2 (en) | 1994-08-24 |
JPH072839A (en) | 1995-01-06 |
NO940524D0 (en) | 1994-02-15 |
DE4304650A1 (en) | 1994-08-18 |
FI940697A (en) | 1994-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL102638A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
IL103053A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
IL108436A0 (en) | Five-membered heterocycles, their preparation and pharmaceutical compositions containing them | |
IL98393A0 (en) | Thiophene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL116957A0 (en) | Substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them | |
HUP9901159A3 (en) | Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds | |
IL110743A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
IL96577A0 (en) | Heterocyclic substituted acylaminothiazoles,their preparation and pharmaceutical compositions containing them | |
HUP0003844A3 (en) | Novel spiroazabicyclic heterocyclic compounds, process for their preparation, their use and pharmaceutical compositions containing them | |
NZ255505A (en) | Substituted thiazolidinedione derivatives, preparation and pharmaceutical compositions thereof | |
HUT74464A (en) | 1n-alkyl-n-arylpyrimidinamines and derivatives thereof, and pharmaceutical compositions containing them | |
IL112193A0 (en) | Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL108648A0 (en) | Condensed five-membered heterocyclic compounds, their preparation and pharmaceutical compositions containing them | |
IL98873A0 (en) | Benzodiazepine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL98756A0 (en) | Pharmaceutical compositions containing benzeneacetamid derivatives,certain such novel compounds and their preparation | |
IL112443A0 (en) | Heterocyclic compounds, their preparation and pharmaceutical compositions containing them | |
IL108703A0 (en) | Substituted azolone derivatives, their preparation and pharmaceutical compositions containing them | |
IL117620A0 (en) | Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL111011A0 (en) | Bisbenzimidazole compounds, their preparation and pharmaceutical compositions containing them | |
IL108800A0 (en) | Heterocyclic compounds, their preparation and pharmaceutical compositions containing them | |
IL106385A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
IL107358A0 (en) | a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
ZA911804B (en) | 1-azabicyclic compounds,processes and pharmaceutical compositions containing them | |
IL103980A0 (en) | Substituted phthalides and heterocyclic phthalides,their preparation and pharmaceutical compositions containing them | |
IL106041A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them |